A novel therapeutic strategy of methicillin-resistant Staphylococcus aureus
Ying Wang , Mengyan Xu , Hanne Ingmer
Engineering Microbiology ›› 2025, Vol. 5 ›› Issue (3) : 100231
A novel therapeutic strategy of methicillin-resistant Staphylococcus aureus
Staphylococcus aureus is a major public health threat, largely due to its remarkable capacity to develop antimicrobial resistance. Zhang et al. recently demonstrated a highly innovative approach to eradicate chronic methicillin-resistant S. aureus infections by inducing bacterial calcification with antibody-polysialic acid conjugates targeting wall teichoic acids, while simultaneously modulating host immune responses via enhanced calprotectin expression and macrophage activation. Despite limitations, this strategy represents a promising and unconventional therapy to combat resistant S. aureus infections.
Methicillin-resistant / taphylococcus aureus / Antimicrobial resistance / Calcification / Antibody-polysialic acid conjugate / Wall teichoic acid
| [1] |
Antimicrobial Resistance Collaborators, Global burden of bacterial antimicrobial re- sistance 1990-2021: a systematic analysis with forecasts to 2050, Lancet 404 (2024) 1199-1226. |
| [2] |
|
| [3] |
Antimicrobial Resistance Collaborators, Global burden of bacterial antimicrobial re- sistance in 2019: a systematic analysis, Lancet 399 (2022) 629-655. |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
/
| 〈 |
|
〉 |